Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1994 Aug 6;309(6951):372–374. doi: 10.1136/bmj.309.6951.372

Variation in coverage by ethnic group of neonatal (Guthrie) screening programme in south London.

A Streetly 1, C Grant 1, G Bickler 1, P Eldridge 1, S Bird 1, W Griffiths 1
PMCID: PMC2541192  PMID: 8081135

Abstract

OBJECTIVES--To determine whether coverage of the neonatal (Guthrie) screening programme in Britain is different for groups at highest risk of sickle cell disease and to identify possible reasons for incomplete coverage. DESIGN--Descriptive study of coverage of screening programme and its variation by mobility, district of residence, and ethnic group. SUBJECTS--1727 infants born between 1 October and 31 December 1991. SETTING--Former West Lambeth and Camberwell District Health Authorities, London. MAIN OUTCOME MEASURE--Proportion of infants with an identifiable screening test result. RESULTS--Screening covered 1663/1727 (96.3%) infants overall (745/786 (94.8%) in West Lambeth; 918/941 (97.6%) in Camberwell). The relative odds ratio of an African infant not having been tested compared with a white infant was 3.05 (95% confidence interval 1.30 to 7.14) (2.08 (0.86 to 5.01) after adjustment for mobility and district of residence). For infants whose families moved into the districts after the birth compared with those born and resident in the districts the relative odds ratio of having been tested was 10.16 (4.85 to 21.29). The odds ratio of locally delivered infants in West Lambeth not having been tested compared with those in Camberwell was 2.12 (1.08 to 4.16) after adjustment for ethnic group. CONCLUSION--Coverage of the screening programme is incomplete and poorer in infants of African ethnic group than in white infants. Poorer coverage is also associated with mobility of the family around the time of birth. The findings have implications for using the neonatal programme for testing for sickle cell disease and other disorders. Arrangements for monitoring the existing screening programme are inadequate and an improved system should be established, similar to the scheme that monitors the immunisation programme.

Full text

PDF
372

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ades A. E., Parker S., Berry T., Holland F. J., Davison C. F., Cubitt D., Hjelm M., Wilcox A. H., Hudson C. N., Briggs M. Prevalence of maternal HIV-1 infection in Thames regions: results from anonymous unlinked neonatal testing. Lancet. 1991 Jun 29;337(8757):1562–1565. doi: 10.1016/0140-6736(91)93260-g. [DOI] [PubMed] [Google Scholar]
  2. Dhondt J. L., Farriaux J. P., Sailly J. C., Lebrun T. Economic evaluation of cost-benefit ratio of neonatal screening procedure for phenylketonuria and hypothyroidism. J Inherit Metab Dis. 1991;14(4):633–639. doi: 10.1007/BF01797933. [DOI] [PubMed] [Google Scholar]
  3. Elliman D., Garner J. Review of neonatal screening programme for phenylketonuria. BMJ. 1991 Aug 24;303(6800):471–471. doi: 10.1136/bmj.303.6800.471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fernhoff P. M., Brown A. L., Elsas L. J. Congenital hypothyroidism: increased risk of neonatal morbidity results in delayed treatment. Lancet. 1987 Feb 28;1(8531):490–491. doi: 10.1016/s0140-6736(87)92098-8. [DOI] [PubMed] [Google Scholar]
  5. Fisher D. A. Effectiveness of newborn screening programs for congenital hypothyroidism: prevalence of missed cases. Pediatr Clin North Am. 1987 Aug;34(4):881–890. doi: 10.1016/s0031-3955(16)36292-7. [DOI] [PubMed] [Google Scholar]
  6. Pharoah P. O., Madden M. P. Audit of screening for congenital hypothyroidism. Arch Dis Child. 1992 Sep;67(9):1073–1076. doi: 10.1136/adc.67.9.1073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Pollitt R. J. Neonatal screening. J Clin Pathol. 1993 Jun;46(6):497–499. doi: 10.1136/jcp.46.6.497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Rattenbury J. M., Brown J. K. Loophole in U.K. screening programme for P.K.U. Lancet. 1978 Aug 26;2(8087):482–483. doi: 10.1016/s0140-6736(78)91498-8. [DOI] [PubMed] [Google Scholar]
  9. Smith I., Cook B., Beasley M. Review of neonatal screening programme for phenylketonuria. BMJ. 1991 Aug 10;303(6798):333–335. doi: 10.1136/bmj.303.6798.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Streetly A., Dick M., Layton M. Sickle cell disease: the case for coordinated information. BMJ. 1993 Jun 5;306(6891):1491–1492. doi: 10.1136/bmj.306.6891.1491. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES